Form 4 for TECH Bio-Techne
Accepted 2023-07-05 00:00:00 ET · period of report 2023-06-30 · accession 0001062993-23-014515 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-07-05 | 2023-06-30 | TECH | Kummeth Charles R. | CEO, Dir | M - OptEx | $26.65 | +616.7K | 1.73M | +55% | +$16.43M |
| D | 2023-07-05 | 2023-06-30 | TECH | Kummeth Charles R. | CEO, Dir | F - Tax | $81.63 | -390.7K | 1.34M | -23% | -$31.90M |
| D | 2023-07-05 | 2023-06-30 | TECH | Kummeth Charles R. | CEO, Dir | M - OptEx | $0.00 | -616.7K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-30 | M | A | 616,676 | $26.65 | 1,729,493 | D | — | — | (F1) Includes (i) 11,448 shares of restricted stock for which the risk of forfeiture will lapse on August 5, 2023; and (ii) 14,248 shares of restricted stock for which the risk of forfeiture will lapse as to 7,128 shares on each of August 6, 2023 and August 6, 2024. |
| 2 | Common | Common Stock | 2023-06-30 | F | D | 390,727 | $81.63 | 1,338,766 | D | — | — | (F1) Includes (i) 11,448 shares of restricted stock for which the risk of forfeiture will lapse on August 5, 2023; and (ii) 14,248 shares of restricted stock for which the risk of forfeiture will lapse as to 7,128 shares on each of August 6, 2023 and August 6, 2024. |
| 3 | Derivative | Stock Options (Right to Buy) | 2023-06-30 | M | D | 616,676 | $0.00 | 0 | D | $26.65 · — to 2023-08-18 | 616,676 Common Stock | (F2) Fully exercisable. |